Showing results (2521-2530 of 6,717) with videos related to
Sort By:
Pageof 672
Oncotargets and Therapy|May 14, 2013
A review of the use of somatostatin analogs in oncologyOzge Keskin, Suayib YalcinOncotargets and Therapy|May 15, 2013
Effect and safety of bevacizumab-containing chemotherapy treatment in Chinese patients with metastatic colorectal cancerQian Wu, Yan Shi, Li Chen, et al.Oncotargets and Therapy|May 15, 2013
Antitumor effects and mechanisms of dendritic cells stimulated by sCD40L on ovarian cancer cells in vitroZheng-Mao Zhang, Xue-Mei Yang, Chao Zhang, et al.Oncotargets and Therapy|April 10, 2013
Dual control of Shuanghuang Shengbai granule on upstream and downstream signal modulators of CyclinD-CDK4/6 signaling pathway of cell cycle in Lewis-bearing mice with cyclophosphamide-induced myelosuppressionXian Gu, Zhen-Ye Xu, Ling-Yu Zhu, et al.Oncotargets and Therapy|April 10, 2013
Epigenetic therapy: use of agents targeting deacetylation and methylation in cancer managementAllen S Ho, Sevin Turcan, Timothy A ChanOncotargets and Therapy|April 10, 2013
Combined measurement of CA 15-3 with novel autoantibodies improves diagnostic accuracy for breast cancerXuejun Dong, Mingfeng Yang, He Sun, et al.Oncotargets and Therapy|April 27, 2013
A brief review of different types of sweat-gland carcinomas in the eyelid and orbitLeilei Zhang, Shengfang Ge, Xianqun FanOncotargets and Therapy|April 27, 2013
Cytotoxic effects of bromelain in human gastrointestinal carcinoma cell lines (MKN45, KATO-III, HT29-5F12, and HT29-5M21)Afshin Amini, Anahid Ehteda, Samar Masoumi Moghaddam, et al.Oncotargets and Therapy|April 17, 2013
Update of research on the role of EZH2 in cancer progressionLiang Shen, Jing Cui, Shumei Liang, et al.Oncotargets and Therapy|March 16, 2013
Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLCValerie Nelson, Jacqueline Ziehr, Mark Agulnik, et al.Pageof 672